Paper Details

  1. Home
  2. Paper Details

Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review.

Author: BakthavatchalamMalini, BrelenMarten E, LaiFrank H P, NgDanny S, RongShi Song

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Oral carbonic anhydrase inhibitors are effective first-line treatments for cystoid macular edema (CME) secondary to retinitis pigmentosa. Oral acetazolamide is the most effective treatment, but topical dorzolamide is a suitable alternative for patients who cannot tolerate oral acetazolamide.
Paper Details　
Original Abstract of the Article :
There are various treatments for cystoid macular edema (CME) secondary to retinitis pigmentosa; however, the evidence for these treatments has not been previously systematically reviewed. Our review that includes 23 studies shows that oral carbonic anhydrase inhibitors (including acetazolamide and m...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.survophthal.2017.09.009

データ提供：米国国立医学図書館（NLM）

Cystoid Macular Edema in Retinitis Pigmentosa: Navigating the Desert of Vision Loss

This study explores the treatment options for cystoid macular edema (CME) in patients with retinitis pigmentosa, a condition that can cause significant vision loss. It's like traversing a desert where vision is fading, seeking out oases of treatment and restoration. The study reviewed various treatments, including oral and topical carbonic anhydrase inhibitors, intravitreal steroids, oral corticosteroids, intravitreal antivascular endothelial growth factor agents, laser photocoagulation, vitrectomy, and ketorolac.

Finding the Right Oasis

The study found that oral carbonic anhydrase inhibitors, such as acetazolamide and methazolamide, are effective first-line treatments for CME in retinitis pigmentosa. It's like discovering a reliable oasis with refreshing waters that can revitalize vision.

A Camel's Journey to Preserving Vision

This research underscores the importance of early intervention and appropriate treatment for CME in retinitis pigmentosa. It's like a camel seeking out water sources before they run dry – proactive measures can help preserve vision and prevent further deterioration.

Dr. Camel's Conclusion

This study provides valuable insights into the treatment options for CME in retinitis pigmentosa, highlighting the need for a personalized approach that considers the individual patient's needs. It's a reminder that the journey to preserving vision requires a combination of knowledge, resources, and perseverance.

Date :
  1. Date Completed 2018-09-14
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28987613

DOI: Digital Object Identifier

10.1016/j.survophthal.2017.09.009

Related Literature

Article Analysis
・Effects of methazolamide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.